A Study On Effectiveness Of Paracervical Block and Requirement of Additional Analgesia

A Study On Monitored Anaesthesia Care And Paracervical Block In Peri and Post Menopausal Women Undergoing Dilatation And Curettage - NIL

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/11/059924

Enrollment

Registered

2023-11-16

Start date

Unknown

Completion date

Unknown

Last updated

2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Paracervical block: Paracervical block is given with 1% Lignocaine 15ml at the cervicovaginal junction before the start of the procedure.patients are monitored through out the procedure

Eligibility

Inclusion criteria

Inclusion criteria: Peri and post menpausal age group ASA II III catagories

Exclusion criteria

Exclusion criteria: ASA I Allergy to local anaesthetic Infection at the site of injection

Design outcomes

Primary

Measure	Time frame
Effectiveness of paracervical blockTimepoint: vas score 5, from baseline to 20mins	—

Secondary

Measure	Time frame
Need for additional analgesia & sedation along with the blockTimepoint: vas score 5 from baseline to 20mins	—

Countries

India

Contacts

Public ContactDr Swathi M R

Shimoga Institute of Medical Sciences

drshrutihiremath@gmail.com9481233634

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026